We're building a groundbreaking treatment tool for metastatic cancer. Our first clinical trial will start at Moffitt Cancer Center in January. Here's an article from Huntsman Cancer Institute on it.

AI is changing healthcare. Clinics must adapt or become irrelevant. New AI tools are creating winners and losers.

Storyline CTO and co-founder Chris Gregg PhD speaking at the University of Calgary to clinicians and others about precision medicine and how new technologies and A.I. will allow for low-cost precision care at massive scale.

Storyline provides a way for you benefit from something valuable you’ve created. It could be a precision care pathway for diabetes, a new patient marketing campaign, or a behavioral biomarker for a drug response.

Today, I'm gonna make a prediction, and that prediction is that within five years, you won't be able to publish clinical research in leading journals if it uses questionnaires or subjective patient reported outcomes.

Chris Gregg PhD, Storyline’s CTO discussing why behavioral data is the richest, most predictive data there is, and why it's better than current tools like genome, epigenome, omics, and lab tests.

Storyline opens all of these areas for anyone with a great idea and the will to make it happen, from building and monetizing even a single care pathway or educational program, to building an entirely new company in a new market.

In the current ecosystem it means writing a grant, getting some funding, running a clinical trial, writing a paper, submitting that paper to journals and finally publishing a paper - one of 2.5 million every year.

67% of the average physician’s time is spent NOT providing care - they’re stuck doing low-level, manual, and repetitive tasks because current tools don’t help them care for patients in the ways they need. To manage, most physicians (57%) grind out more than 70 hours a week.

“The most striking finding of our study of what people want from their health care is that every participant answered this question as to what they wanted from the doctor. ”

In the growing A.I. and big data revolution, how are foundational R01 researchers going to compete, discover and lead in a climate where the biggest companies in the world are doing more than just generating products – they are doing research?!

Cancer patients are overwhelmed, suffering needlessly, and dying sooner because they’re powerless to engage in their own care in ways that will improve their outcomes. What matters? What doesn’t? What information can I trust? How do I decide?

Storyline offers grants to eligible researchers and institutions anywhere in the World to provide unlimited free use of Storyline data collection and interaction platform, bioinformatics, and advanced data science analyses (machine learning).

NYSCF partners with Storyline to bring AI behavioral science to cancer patients. Storyline is the leader in precision healthcare using human behavior.